Site search
Correspondence address
310 Mira Street, Stavropol, Russia, 355017
Tel
+7 865 2352511, +7 865 2353229.
E-mail
medvestnik@stgmu.ru
The journal is included into The list of leading scientific periodicals.
The journal is included into VINITI database and is registered in Electronic scientific library.
The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.
[Experimental medicine]
Oleg Robertovich Khabarov; Evgeniya Yurievna Zyablitskaya; Tatiana Pavlovna Makalish; Elvina Refatovna Asanova; Anatoly Vladimirovich Kubyshkin;
Coronavirus causing severe acute respiratory syndrome (SARS-CoV-2) triggers autoimmune cross-responses in thyroid tissues, which is due to antigenic mimicry and cytokine storm. This article offers a view at the results of morphological and immunohistochemical studies of the thyroid gland in an experiment carried out with Syrian hamsters infected with SARS-CoV-2. There were effects of a mild form of the disease studied, which were to be observed within the period of 5–30 days. The most significant differences were to be noted on Day 10; such differences reflect changes in the processes of the cell cycle, angiogenesis and the extracellular matrix rearrangements. There were processes observed such as activated angiogenesis, decreasing or wave like changes in the matrix metalloproteinases expression in thyrocytes, activated expression of cyclin D1 and a proapoptotic factor, as well as reduced activity of the pro-oncogenic protein p53. In females, there was an increase in the activity of macrophages and B-lymphocytes identified on Day 10, whereas in males, the number of macrophages, plasma cells and T-helpers increased on Day 5. On Day 30, the number of activated T- and B-cells in convalescents was found to exceed the control, which points at an active, long-lasting immune inflammatory response.
References:
1. Caron P. Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management. Ann. Endocrinol. (Paris). 2020;81(5):507-510. https://doi.org/10.1016/j.ando.2020.09.001
2. Parolin M., Parisotto M., Zanchetta F., Sartorato P., DeMenis E. Coronaviruses and endocrine system: a systematic review on evidences and shadows. Endocr. Metab. Immune. Disord. Drug. Targets. 2021;21(7):1242-1251. https://doi.org/10.2174/1871530320666200905123332
3. Marazuela M., Giustina A., Puig-Domingo M. Endocrineand metabolic aspects of the COVID-19 pandemic. Rev. Endocr. Metab. Disord. 2020;21(4):495-507. https://doi.org/10.1007/s1115 4-020-09569-2
4. Kothandaraman N., Rengaraj A., Xue B., Yew W. S., Velan S. S. [et al.]. COVID-19 endocrinopathy with hindsight from SARS. Am. J. Physiol. Endocrinol. Metab. 2021;320(1):E139-E150. https://doi.org/10.1152/ajpendo.00480.2020
5. Chen W., Tian Y., Li Z., Zhu J., Wei T., Lei J. Potential Interaction Between SARS-CoV-2 and Thyroid: A Review. Endocrinology. 2021;162(3):bqab004. https://doi.org/10.1210/endocr/bqab004
6. Lanzola G., Marcocci C., Marinò M. Graves’ disease and Graves’ orbitopathy folowing COVID-19. J. Endocrinol. Invest. 2021;44(9):2011-2012. https://doi.org/10.1007/s40618-021-01576-7
7. Giovanella L., Ruggeri R. M., Ovčariček P. P., Campenni A., Treglia G., Deandreis D. Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review. Clin. Transl. Imaging. 2021;9:233-240. https://doi.org/10.1007/s40336-021-00419-y
8. Gorini F., Bianchi F., Iervasi G. COVID-19 and Thyroid: Progress and Prospects. Int. J. Environ. Res. Public. Health. 2020;17(18):6630. https://doi.org/10.3390/ijerph17186630
9. Sia S. F., Yan L. M., Chin A. W. H., Fung K., Choy K. [et al.]. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583(7818):834-838. https://doi:org/10.1038/s41586-020-2342
Keywords: thyroid gland, pathological physiology, histological structure, SARS-CoV-2 virus, autoimmune thyroiditis